Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloid
PrecivityAD2血液检测的临床验证:一种基于质谱的检测方法,其算法结合了%p-tau217和Aβ42/40比值,用于识别脑淀粉样蛋白的存在。
期刊:Alzheimers & Dementia
影响因子:11.1
doi:10.1002/alz.13764
Meyer, Matthew R; Kirmess, Kristopher M; Eastwood, Stephanie; Wente-Roth, Traci L; Irvin, Faith; Holubasch, Mary S; Venkatesh, Venky; Fogelman, Ilana; Monane, Mark; Hanna, Lucy; Rabinovici, Gil D; Siegel, Barry A; Whitmer, Rachel A; Apgar, Charles; Bateman, Randall J; Holtzman, David M; Irizarry, Michael; Verbel, David; Sachdev, Pallavi; Ito, Satoshi; Contois, John; Yarasheski, Kevin E; Braunstein, Joel B; Verghese, Philip B; West, Tim